Fawwaz Al-Smadi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Fawwaz Al-Smadi has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
- Guohui Liu
Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
8 shared publications Bobin Mi
Department of Orthopedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277, Jiefang Avenue, Wuhan, 430022, China
5 shared publicationsJiewen Liao
5 shared publicationsLizhi Ouyang
5 shared publicationsXudong Xie
3 shared publicationsYanzhi Zhao
3 shared publications
Latest Publications
- Open Access
- 1 March 2027
- Published by KEAI Publishing in Bioactive Materials
- Vol. 69, 33-51
Aptamer-functionalized EGCG nanocarrier for neutrophil-targeted AKBA delivery promotes anxiety-related fracture healing
- 1 March 2027
- Published by KEAI Publishing in Bioactive Materials
- Vol. 69, 33-51
Open AccessAptamer-functionalized EGCG nanocarrier for neutrophil-targeted AKBA delivery promotes anxiety-related fracture healing
- Open Access
- 18 November 2026
- Published by Wiley in Advanced Science
CaSiO 3 ‐Engineered Extracellular Vesicles Promote Diabetic Fracture Healing in Mice via the PGC‐1α–miR‐363‐3p–DKK3–β‐Catenin Axis
Diabetes impairs fracture healing. In diabetic mice, we found that PGC‐1α expression is downregulated in bone marrow mesenchymal stem cell (BMSC). PGC‐1α levels positively correlate with osteogenic capacity. Physiologically, reduced PGC‐1α suppresses miR‐363‐3p expression; mechanistically, this further inhibits DKK3, thereby promoting β‐catenin phosphorylation and degradation, which in turn inhibits osteogenesis in BMSCs. To target this pathway, we treated BMSC with calcium silicate (CaSiO 3 ). CaSiO 3 inhibited the ubiquitination‐mediated degradation of PGC‐1α, restoring miR‐363‐3p expression. It also upregulated AGO2, which facilitated the assembly of miR‐363‐3p into mi‐RISC complexes and their loading into extracellular vesicles. We then engineered a ROS‐responsive hydrogel (Gel ROS ) to deliver these CaSiO 3 ‐engineered extracellular vesicles (EVs). In diabetic mice with femoral fractures, the hydrogel enabled sustained, on‐demand release of EVs specifically at sites with high ROS levels. The released EVs, enriched with miRISC complexes, suppressed the DKK3‐β‐catenin axis in recipient BMSC, enhanced osteogenesis, and accelerated fracture healing. This study identifies the PGC‐1α–miR‐363‐3p–DKK3‐β–catenin axis as a key pathway in diabetic fracture healing. It also presents a novel EVs‐based strategy that avoids direct CaSiO 3 toxicity, offering a new translational approach for treating diabetic bone defects.
- 18 November 2026
- Published by Wiley in Advanced Science
Open AccessCaSiO 3 ‐Engineered Extracellular Vesicles Promote Diabetic Fracture Healing in Mice via the PGC‐1α–miR‐363‐3p–DKK3–β‐Catenin Axis
Diabetes impairs fracture healing. In diabetic mice, we found that PGC‐1α expression is downregulated in bone marrow mesenchymal stem cell (BMSC). PGC‐1α levels positively correlate with osteogenic capacity. Physiologically, reduced PGC‐1α suppresses miR‐363‐3p expression; mechanistically, this further inhibits DKK3, thereby promoting β‐catenin phosphorylation and degradation, which in turn inhibits osteogenesis in BMSCs. To target this pathway, we treated BMSC with calcium silicate (CaSiO 3 ). CaSiO 3 inhibited the ubiquitination‐mediated degradation of PGC‐1α, restoring miR‐363‐3p expression. It also upregulated AGO2, which facilitated the assembly of miR‐363‐3p into mi‐RISC complexes and their loading into extracellular vesicles. We then engineered a ROS‐responsive hydrogel (Gel ROS ) to deliver these CaSiO 3 ‐engineered extracellular vesicles (EVs). In diabetic mice with femoral fractures, the hydrogel enabled sustained, on‐demand release of EVs specifically at sites with high ROS levels. The released EVs, enriched with miRISC complexes, suppressed the DKK3‐β‐catenin axis in recipient BMSC, enhanced osteogenesis, and accelerated fracture healing. This study identifies the PGC‐1α–miR‐363‐3p–DKK3‐β–catenin axis as a key pathway in diabetic fracture healing. It also presents a novel EVs‐based strategy that avoids direct CaSiO 3 toxicity, offering a new translational approach for treating diabetic bone defects.
- Open Access
- 16 September 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (38) , e71700
PLL‐g‐HPA Hydrogel Microneedles Loaded With Rhoifolin Target Macrophages to Alleviate Fibroblast Senescence for Diabetic Wound Healing
In this study, we demonstrate that during diabetic wound healing, interleukin‐11 (IL‐11) promotes the M1 polarization of macrophages, which subsequently triggers fibroblast senescence through the enhanced release of pro‐inflammatory cytokines IL‐1β and IL‐6. Notably, Rhoifolin (Rho) effectively inhibits IL‐11‐induced M1 polarization, alleviates the secretion of IL‐1β and IL‐6, and concurrently promotes the release of choline, thereby mitigating fibroblast senescence. Based on these mechanistic findings, we constructed a targeted delivery system by loading Rho into mesoporous silica nanoparticles and coating them with macrophage membranes (M‐Rho). The M‐Rho were then incorporated into a poly(L‐lysine)‐grafted hyperbranched poly(amidoamine) (PLL‐ g ‐HPA) hydrogel to fabricate microneedles (Gel@M‐Rho MN). This integrated system enables macrophage targeting, controlled drug release, favorable mechanical properties, and excellent biocompatibility. Moreover, the system exhibits potent reactive oxygen species (ROS)‐scavenging activity and effectively inhibits the growth of Escherichia coli and Staphylococcus aureus . In vivo animal studies confirmed that Gel@M‐Rho MN significantly promotes M2 macrophage polarization, suppresses fibroblast senescence, and accelerates wound closure, angiogenesis, and collagen deposition. Collectively, this strategy, which modulates macrophage‐fibroblast crosstalk, offers a multi‐mechanistic synergistic therapeutic approach for diabetic wounds, holding substantial potential for clinical translation.
- 16 September 2026
- Published by Wiley in Advanced Healthcare Materials
- Vol. 15 (38) , e71700
Open AccessPLL‐g‐HPA Hydrogel Microneedles Loaded With Rhoifolin Target Macrophages to Alleviate Fibroblast Senescence for Diabetic Wound Healing
In this study, we demonstrate that during diabetic wound healing, interleukin‐11 (IL‐11) promotes the M1 polarization of macrophages, which subsequently triggers fibroblast senescence through the enhanced release of pro‐inflammatory cytokines IL‐1β and IL‐6. Notably, Rhoifolin (Rho) effectively inhibits IL‐11‐induced M1 polarization, alleviates the secretion of IL‐1β and IL‐6, and concurrently promotes the release of choline, thereby mitigating fibroblast senescence. Based on these mechanistic findings, we constructed a targeted delivery system by loading Rho into mesoporous silica nanoparticles and coating them with macrophage membranes (M‐Rho). The M‐Rho were then incorporated into a poly(L‐lysine)‐grafted hyperbranched poly(amidoamine) (PLL‐ g ‐HPA) hydrogel to fabricate microneedles (Gel@M‐Rho MN). This integrated system enables macrophage targeting, controlled drug release, favorable mechanical properties, and excellent biocompatibility. Moreover, the system exhibits potent reactive oxygen species (ROS)‐scavenging activity and effectively inhibits the growth of Escherichia coli and Staphylococcus aureus . In vivo animal studies confirmed that Gel@M‐Rho MN significantly promotes M2 macrophage polarization, suppresses fibroblast senescence, and accelerates wound closure, angiogenesis, and collagen deposition. Collectively, this strategy, which modulates macrophage‐fibroblast crosstalk, offers a multi‐mechanistic synergistic therapeutic approach for diabetic wounds, holding substantial potential for clinical translation.
- Open Access
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 484-505
Polysaccharide-engineered mitochondria reprogram macrophages to resolve diabetic wound inflammation and promote repair
Chronic diabetic wounds are characterized by persistent inflammation, defective resolution and impaired tissue regeneration, in which macrophage dysfunction and mitochondrial damage play central roles. Here, we developed a macrophage-targeted engineered mitochondrial transplantation system by coating adipose-derived stem cell (ADSC) mitochondria with triphenylphosphonium-modified konjac glucomannan (Mito-TPP-KGM). This design preserves mitochondrial membrane potential and ATP production while reducing ROS generation, and provides a mannose-rich corona for lectin receptor-related uptake. In RAW264.7 macrophages exposed to high glucose plus H2O2 or LPS, Mito-TPP-KGM is efficiently internalized, restores mitochondrial homeostasis, rebalances glycolysis and oxidative phosphorylation, and shifts inflammatory profiles toward a less inflammatory and more reparative phenotype. Engineered mitochondria also restore efferocytosis of apoptotic neutrophil-like cells and enhance the pro-angiogenic capacity of macrophage-conditioned media, thereby improving endothelial tube formation, migration and proliferation. Blocking experiments with mannan and anti-CD206/anti-DC-SIGN antibodies, together with species-specific mtDNA quantification, indicate that mannose-type lectin receptors contribute to the uptake and immunomodulatory effects of Mito-TPP-KGM. In a db/db mouse full-thickness wound model, local delivery of Mito-TPP-KGM promotes wound repair, improves histological healing, reduces oxidative damage, enhances angiogenesis, and modulates wound macrophage phenotype, leading to accelerated wound closure; these therapeutic benefits are partially attenuated by local CD206 blockade. Collectively, these findings demonstrate that polysaccharide-engineered mitochondria can reprogram diabetic wound macrophages via targeted mitochondrial transplantation, offering a promising immunometabolic strategy for chronic wound therapy.
- 1 September 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 63, 484-505
Open AccessPolysaccharide-engineered mitochondria reprogram macrophages to resolve diabetic wound inflammation and promote repair
Chronic diabetic wounds are characterized by persistent inflammation, defective resolution and impaired tissue regeneration, in which macrophage dysfunction and mitochondrial damage play central roles. Here, we developed a macrophage-targeted engineered mitochondrial transplantation system by coating adipose-derived stem cell (ADSC) mitochondria with triphenylphosphonium-modified konjac glucomannan (Mito-TPP-KGM). This design preserves mitochondrial membrane potential and ATP production while reducing ROS generation, and provides a mannose-rich corona for lectin receptor-related uptake. In RAW264.7 macrophages exposed to high glucose plus H2O2 or LPS, Mito-TPP-KGM is efficiently internalized, restores mitochondrial homeostasis, rebalances glycolysis and oxidative phosphorylation, and shifts inflammatory profiles toward a less inflammatory and more reparative phenotype. Engineered mitochondria also restore efferocytosis of apoptotic neutrophil-like cells and enhance the pro-angiogenic capacity of macrophage-conditioned media, thereby improving endothelial tube formation, migration and proliferation. Blocking experiments with mannan and anti-CD206/anti-DC-SIGN antibodies, together with species-specific mtDNA quantification, indicate that mannose-type lectin receptors contribute to the uptake and immunomodulatory effects of Mito-TPP-KGM. In a db/db mouse full-thickness wound model, local delivery of Mito-TPP-KGM promotes wound repair, improves histological healing, reduces oxidative damage, enhances angiogenesis, and modulates wound macrophage phenotype, leading to accelerated wound closure; these therapeutic benefits are partially attenuated by local CD206 blockade. Collectively, these findings demonstrate that polysaccharide-engineered mitochondria can reprogram diabetic wound macrophages via targeted mitochondrial transplantation, offering a promising immunometabolic strategy for chronic wound therapy.
- Open Access
- 1 July 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 61, 136-149
Dynamic hydrogels orchestrate the differentiation fate of mesenchymal stem cells through epigenetic regulation of SETD7 to accelerate bone defect repair
Dynamic mechanical signaling of the extracellular matrix is a key determinant of mesenchymal stem cell (MSC) fate, closely regulating their proliferation, differentiation and migration. Previously, we developed a highly cell-adaptive dynamic hydrogel (HA-ADA) that modulates MSC fate through unknown mechanisms. Here, using human bone marrow-derived mesenchymal stem cells (hMSCs), we found that sustained mechanical stimulation provided by HA-ADA hydrogel induced rapid spreading and significantly enhanced their osteogenic differentiation while inhibiting adipogenesis. Mechanistically, miRNA sequencing revealed that this process was mediated by the downregulation of miR-376a-3p and miR-127-5p, thereby relieving their inhibitory effect on the methyltransferase SETD7. Elevated SETD7 expression catalyzed methylation of β-catenin and accelerated its nuclear translocation. In the nucleus, β-catenin further formed a transcriptional complex with YAP to synergistically amplify downstream signals and potently activate the expression of Runx2, a key transcription factor for osteogenesis, which ultimately drove osteogenic differentiation and inhibited adipogenesis. The present study elucidated a novel mechanism by which cell-adaptive hydrogels regulate the β-catenin/YAP signaling loop through the miR-376a-3p/miR-127-5p-SETD7 axis, thereby determining the osteogenic/adipogenic differentiation of stem cells, which not only deepens our understanding of mechanotransduction but also provides new targets and material design strategies for bone regeneration.
- 1 July 2026
- Published by KEAI Publishing in Bioactive Materials
- Vol. 61, 136-149
Open AccessDynamic hydrogels orchestrate the differentiation fate of mesenchymal stem cells through epigenetic regulation of SETD7 to accelerate bone defect repair
Dynamic mechanical signaling of the extracellular matrix is a key determinant of mesenchymal stem cell (MSC) fate, closely regulating their proliferation, differentiation and migration. Previously, we developed a highly cell-adaptive dynamic hydrogel (HA-ADA) that modulates MSC fate through unknown mechanisms. Here, using human bone marrow-derived mesenchymal stem cells (hMSCs), we found that sustained mechanical stimulation provided by HA-ADA hydrogel induced rapid spreading and significantly enhanced their osteogenic differentiation while inhibiting adipogenesis. Mechanistically, miRNA sequencing revealed that this process was mediated by the downregulation of miR-376a-3p and miR-127-5p, thereby relieving their inhibitory effect on the methyltransferase SETD7. Elevated SETD7 expression catalyzed methylation of β-catenin and accelerated its nuclear translocation. In the nucleus, β-catenin further formed a transcriptional complex with YAP to synergistically amplify downstream signals and potently activate the expression of Runx2, a key transcription factor for osteogenesis, which ultimately drove osteogenic differentiation and inhibited adipogenesis. The present study elucidated a novel mechanism by which cell-adaptive hydrogels regulate the β-catenin/YAP signaling loop through the miR-376a-3p/miR-127-5p-SETD7 axis, thereby determining the osteogenic/adipogenic differentiation of stem cells, which not only deepens our understanding of mechanotransduction but also provides new targets and material design strategies for bone regeneration.
- Open Access
- 25 February 2026
- Published by Elsevier in Surgery Case Reports
- Vol. 7
Bilateral posterior shoulder fracture-dislocation following low-energy trauma treated with 3D-printed surgical planning: A case report and literature review
- 25 February 2026
- Published by Elsevier in Surgery Case Reports
- Vol. 7
Open AccessBilateral posterior shoulder fracture-dislocation following low-energy trauma treated with 3D-printed surgical planning: A case report and literature review
- Open Access
- 18 February 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102931
MicroRNA-493-5p engineered exosomes delivered via piezoelectric microneedles for epigenetic modulation of macrophages in diabetic wound healing
- 18 February 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102931
Open AccessMicroRNA-493-5p engineered exosomes delivered via piezoelectric microneedles for epigenetic modulation of macrophages in diabetic wound healing
- Top Cited PapersOpen Access
- 1 January 2026
- Published by Ivyspring International Publisher in Theranostics
- Vol. 16 (1) , 516-544
Recent advances and challenges in hydrogel-based delivery of immunomodulatory strategies for diabetic wound healing
Chronic wounds associated with diabetes present considerable clinical hurdles, primarily due to delayed tissue repair and dysregulated immune activity. The imbalance in immune responses, including impaired macrophage polarization, excessive neutrophil activation, and oxidative stress, further hampers the healing process. The application of immunomodulatory biologics as a novel treatment method for diabetic wounds often yields limited results due to rapid degradation and lack of targeting. Hydrogels not only prevent rapid drug degradation but also allow for conditional responsiveness and targeted delivery. Therefore, hydrogels loaded with immunomodulatory biologics emerge as a promising strategy, offering the capacity to reshape the immune milieu and promote regenerative outcomes. This review first outlines the role of immune system during the healing processes in normal and diabetic wounds. It then discusses the latest advancements in hydrogel delivery systems as part of immune-modulatory interventions, wherein hydrogels serve as pivotal carriers for (i) cell delivery, such as stem cells and macrophages; (ii) extracellular vesicles derived from both cellular and tissue sources, as well as extracellular vesicle mimetics; and (iii) bioactive substances, including oxygen-releasing microspheres, nanomaterials, and cytokines. Finally, this review focuses on the limitations of modulating immune responses in diabetic wound healing and proposes potential future directions.
- 1 January 2026
- Published by Ivyspring International Publisher in Theranostics
- Vol. 16 (1) , 516-544
Top Cited PapersOpen AccessRecent advances and challenges in hydrogel-based delivery of immunomodulatory strategies for diabetic wound healing
Chronic wounds associated with diabetes present considerable clinical hurdles, primarily due to delayed tissue repair and dysregulated immune activity. The imbalance in immune responses, including impaired macrophage polarization, excessive neutrophil activation, and oxidative stress, further hampers the healing process. The application of immunomodulatory biologics as a novel treatment method for diabetic wounds often yields limited results due to rapid degradation and lack of targeting. Hydrogels not only prevent rapid drug degradation but also allow for conditional responsiveness and targeted delivery. Therefore, hydrogels loaded with immunomodulatory biologics emerge as a promising strategy, offering the capacity to reshape the immune milieu and promote regenerative outcomes. This review first outlines the role of immune system during the healing processes in normal and diabetic wounds. It then discusses the latest advancements in hydrogel delivery systems as part of immune-modulatory interventions, wherein hydrogels serve as pivotal carriers for (i) cell delivery, such as stem cells and macrophages; (ii) extracellular vesicles derived from both cellular and tissue sources, as well as extracellular vesicle mimetics; and (iii) bioactive substances, including oxygen-releasing microspheres, nanomaterials, and cytokines. Finally, this review focuses on the limitations of modulating immune responses in diabetic wound healing and proposes potential future directions.
- 28 November 2025
- Published by OPRA Publications in International Journal of Advanced Multidisciplinary Research and Studies
- Vol. 5 (6) , 954-961
YOLOv11 Models: Enhancing CT-Based Diagnosis of Cervical Foraminal Stenosis Through Deep Learning
This study aims to construct a deep learning (DL) system from the YOLOv11 family by using computed tomography (CT) to overcome the scarcity of magnetic resonance imaging (MRI) availability and the standard imaging assessments to diagnose cervical foramina stenosis (CFS). This retrospective study involved 1,437 cervical spine CT scans from three centers (Center A, B, and C) of a local hospital. The training and validation were done using scans from Centers A and B, with Center C used as the external test set. A stenosis detection model, based on the YOLOv11 architecture with Multiplanar Reconstruction (MPR) technology, was employed. The model was trained on 5-fold cross-validated images (640×640 pixels) in five variants (n, s, m, l, x) that were labeled. Five radiologists analyzed 215 images from Center C, and performance metrics were determined. Statistical analysis was conducted using paired t-tests and McNemar tests, with Bonferroni and FDR corrections. In external testing (n = 215), the YOLOv11-x model had higher diagnostic performance at detecting cervical foraminal stenosis: sensitivity was 95.6% (p = 0.005), specificity was 97.4% (p < 0.001), and accuracy was 96.7% (p < 0.001). YOLOv11-x has demonstrated high performance in standardized CT-based diagnosis of CFS, and lightweight versions could be used in real-time clinical applications. This technique presents a deep learning modality, which is effective as an alternative diagnostic tool in settings with limited MRI resources. Future validation and correlation with clinical outcomes should verify the generalizability of treatment responses and symptom severity results.
- 28 November 2025
- Published by OPRA Publications in International Journal of Advanced Multidisciplinary Research and Studies
- Vol. 5 (6) , 954-961
YOLOv11 Models: Enhancing CT-Based Diagnosis of Cervical Foraminal Stenosis Through Deep Learning
This study aims to construct a deep learning (DL) system from the YOLOv11 family by using computed tomography (CT) to overcome the scarcity of magnetic resonance imaging (MRI) availability and the standard imaging assessments to diagnose cervical foramina stenosis (CFS). This retrospective study involved 1,437 cervical spine CT scans from three centers (Center A, B, and C) of a local hospital. The training and validation were done using scans from Centers A and B, with Center C used as the external test set. A stenosis detection model, based on the YOLOv11 architecture with Multiplanar Reconstruction (MPR) technology, was employed. The model was trained on 5-fold cross-validated images (640×640 pixels) in five variants (n, s, m, l, x) that were labeled. Five radiologists analyzed 215 images from Center C, and performance metrics were determined. Statistical analysis was conducted using paired t-tests and McNemar tests, with Bonferroni and FDR corrections. In external testing (n = 215), the YOLOv11-x model had higher diagnostic performance at detecting cervical foraminal stenosis: sensitivity was 95.6% (p = 0.005), specificity was 97.4% (p < 0.001), and accuracy was 96.7% (p < 0.001). YOLOv11-x has demonstrated high performance in standardized CT-based diagnosis of CFS, and lightweight versions could be used in real-time clinical applications. This technique presents a deep learning modality, which is effective as an alternative diagnostic tool in settings with limited MRI resources. Future validation and correlation with clinical outcomes should verify the generalizability of treatment responses and symptom severity results.
- Open Access
- 10 October 2025
- Published by Elsevier in Chemical Engineering Journal
- Vol. 524
Targeting mitochondrial copper(II) for epigenetic modulation of macrophage polarization to prevent senile osteoporosis
- 10 October 2025
- Published by Elsevier in Chemical Engineering Journal
- Vol. 524
Open AccessTargeting mitochondrial copper(II) for epigenetic modulation of macrophage polarization to prevent senile osteoporosis